Mylan might make do with only 50% of Perrigo

Mylan could settle for buying control of Perrigo, rather than full ownership, keeping Perrigo listed on the TASE.

Robert-J-Coury-1 Mylan


Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) deal from 80% to 50%. This means that under certain circumstances, Mylan could settle for acquiring control of Perrigo, without acquiring full ownership of the company.

Read the full story, click here

GLOBES logo-eng (1)Published by Globes [online], Israel business news –



Read more about: , , , , , ,

Wordpress site Developed by Fixing WordPress Problems